natgillin/translations-raw huggingface dataset:
In this study, 53 patients received placebo, 214 patients received 50 mg Enbrel once weekly and 153 patients received 25 mg Enbrel twice weekly. 
V tej študiji je 53 bolnikov dobivalo placebo, 214 bolnikov 50 mg zdravila Enbrel enkrat na teden in 153 bolnikov 25 mg zdravila Enbrel dvakrat na teden.
*Some patients did not provide complete data for each endpoint **ASAS=Assessments in Spondyloarthritis International Society ***Bath Ankylosing Spondylitis Disease Activity Index a: p <0.001, b:<0.01 and c:<0.05, respectively between Enbrel and placebo 
** ASAS = Mednarodno združenje za ocenjevanje spondilartritisa *** Indeks Bath za ocenjevanje aktivnosti ankilizirajočega spondilitisa a: p < 0,001, b: < 0,01 oziroma c: < 0,05 med zdravilom Enbrel in placebom
However, your doctor may determine an alternative frequency at which to inject Enbrel. 
Zdravnik vam lahko predpiše tudi drugačno pogostnost injiciranja zdravila Enbrel.
• If you are not sure how to fill your syringe ask your doctor or nurse. 
Če niste prepričani, kako napolniti injekcijsko brizgo, vprašajte zdravnika ali medicinsko sestro.
Before preparing the Enbrel solution, Enbrel may be stored outside of the refrigerator at temperatures up to a maximum of 25°C for a single period of up to four weeks; after which, it should not be refrigerated again. 
Pred pripravo raztopine zdravila Enbrel lahko zdravilo Enbrel shranjujete izven hladilnika pri temperaturi do največ 25 °C za enkratno obdobje do štirih tednov, po katerem se ga ne sme več ohladiti.
Caution should be exercised in patients being treated with Enbrel who have a previous history of blood dyscrasias. 
Previdnost je potrebna pri bolnikih, zdravljenih z zdravilom Enbrel, ki imajo krvno diskrazijo v anamnezi.
There have been postmarketing reports of worsening of CHF, with and without identifiable precipitating factors, in patients taking Enbrel. 
Obstajajo poročila iz obdobja trženja o poslabšanju KSP pri bolnikih, ki jemljejo zdravilo Enbrel, ob prisotnosti dejavnikov, ki bi lahko sprožili tako poslabšanje, in brez njih.
Patients in this study received a dose of 50 mg Enbrel or placebo once weekly for 12 weeks and then all patients received open-label 50 mg Enbrel once weekly for an additional 12 weeks. 
Bolniki v tej študiji so dobivali odmerek 50 mg zdravila Enbrel ali placebo enkrat na teden 12 tednov, potem pa so vsi bolniki v odprtem delu dobivali 50 mg zdravila Enbrel enkrat na teden dodatnih 12 tednov.
In an open-label, safety extension study, 58 paediatric patients from the above study (from the age of 4 years at time of enrolment) continued to receive Enbrel for up to 10 years. 
Varnost uporabe zdravila so spremljali v odprtem podaljšku študije, v katerem se je 58 otrok iz zgoraj omenjene študije (v času vključitve so bili stari 4 leta ali več) z zdravilom Enbrel zdravilo do 10 let.
• Inflammatory bowel disease (IBD): There have been cases of IBD in patients with juvenile idiopathic arthritis (JIA) treated with Enbrel. 
• Kronična vnetna črevesna bolezen (KVČB): Pri bolnikih z juvenilnim idiopatskim artritisom (JIA), ki so se zdravili z zdravilom Enbrel, so poročali o primerih KVČB.
Various malignancies have also been reported with use of Enbrel, including cancers of the breast, lung, skin and lymph glands (lymphoma). 
Pri uporabi zdravila Enbrel so poročali tudi o pojavu različnih malignih obolenj, vključno z rakom dojke, pljuč, kože in bezgavk (limfom).
For psoriasis in patients from the age of 6 years, the usual dose is 0.8 mg of Enbrel per kg bodyweight (up to a maximum of 50 mg), and should be given once weekly. 
Za psoriazo pri bolnikih od 6. leta starosti naprej je običajni odmerek 0,8 mg zdravila Enbrel na kg telesne mase (do največ 50 mg), dajati pa ga je treba enkrat na teden.
Histiocytosis haematophagic (macrophage activation syndrome)† 
hematofagna histiocitoza (sindrom aktivacije makrofagov)
• With the Enbrel vial upright on a flat surface, such as a table, insert the syringe needle straight down through the centre ring of the grey stopper of the vial (see Diagram 2). 
Ko je viala z zdravilom Enbrel postavljena pokončno na ravni površini, na primer mizi, zabodite iglo brizge naravnost navzdol skozi osrednji obroč sivega zamaška viale (glejte sliko 2).
This will help reduce foaming (lots of bubbles) (see Diagram 5). 
Tako boste zmanjšali penjenje raztopine (nastajanje mehurčkov) (glejte sliko 5).
In another active-controlled, double-blind, randomised study, clinical efficacy, safety, and radiographic progression in RA patients treated with Enbrel alone (25 mg twice weekly), methotrexate alone (7.5 to 20 mg weekly, median dose 20 mg), and the combination of Enbrel and methotrexate initiated concurrently were compared in 682 adult patients with active rheumatoid arthritis of 6 months to 20 years duration (median 5 years) who had a less than satisfactory response to at least 1 diseasemodifying antirheumatic drug (DMARD) other than methotrexate. 
V drugi dvojno slepi randomizirani študiji, nadzorovani z učinkovino, so primerjali klinično učinkovitost, varnost in radiografsko napredovanje pri bolnikih z revmatoidnim artritisom, ki so jih zdravili samo z zdravilom Enbrel (25 mg 2-krat na teden), samo z metotreksatom (7,5 do 20 mg na teden, mediani odmerek 20 mg) ali z zdravilom Enbrel in metotreksatom (s sočasnim začetkom), in sicer pri 682 odraslih bolnikih z aktivnim revmatoidnim artritisom, pri katerih je bolezen trajala od 6 mesecev do 20 let (mediano trajanje 5 let) in pri katerih je bil odziv na najmanj eno od imunomodulirajočih antirevmatičnih zdravil (DMARD), razen metotreksata, manj kot zadovoljiv.
• if you, or the child you are caring for, are allergic to etanercept or any of the other ingredients of Enbrel (listed in section 6). 
Ne uporabljajte zdravila Enbrel če ste vi ali otrok, za katerega skrbite, alergični na etanercept ali katerokoli sestavino tega zdravila (navedeno v poglavju 6).
There is generally no applicable use of Enbrel in children aged below 6 years in the indication plaque psoriasis. 
Zdravila Enbrel se običajno ne uporablja za zdravljenje psoriaze v plakih pri otrocih, mlajših od 6 let.
• if the child you are caring for is allergic to etanercept or any of the other ingredients of Enbrel (listed in section 6). 
Ne uporabljajte zdravila Enbrel če je otrok, za katerega skrbite, alergičen na etanercept ali katerokoli sestavino tega zdravila (navedeno v poglavju 6).
The safety and efficacy of 50 mg Enbrel (two 25 mg SC injections) administered once weekly were evaluated in a double-blind, placebo-controlled study of 420 patients with active RA. 
Varnost in učinkovitost 50 mg zdravila Enbrel (dve subkutani injekciji po 25 mg) enkrat na teden so ocenili v dvojno slepi, s placebom nadzorovani študiji pri 420 bolnikih z aktivnim revmatoidnim artritisom.
• Severe rash, itching, or hives (elevated patches of red or pale skin that often itch) 
hud izpuščaj, srbenje ali koprivnica (rdeče ali blede kožne spremembe nad ravnijo kože, ki pogosto srbijo).
• Once the solvent is added to the Enbrel, the plunger may move up by itself. 
Ko je vehikel dodan zdravilu Enbrel, se lahko zgodi, da se bat brizge sam pomakne navzgor.
• Infections/surgery: If you or the child develop a new infection, or are about to have any major surgery, your doctor may wish to monitor the treatment with Enbrel. 
Okužbe/operacije: Če se pri vas ali otroku pojavi nova okužba ali če je pri vas ali otroku predvidena kakršnakoli večja operacija, bo zdravnik morda želel spremljati zdravljenje z zdravilom Enbrel.
However, any of the above symptoms may indicate an allergic reaction to Enbrel, so you should seek immediate medical attention. 
Resne alergijske reakcije so redke, vendar pa lahko katerikoli od zgoraj navedenih simptomov kaže na pojav alergijske reakcije na zdravilo Enbrel, zato morate nemudoma poiskati zdravniško pomoč.
• Cancer: Tell your doctor if you have or have ever had lymphoma (a type of blood cancer) or any other cancer before you are given Enbrel. 
Rak: Preden boste prejeli zdravilo Enbrel, povejte zdravniku, če imate ali ste kdaj imeli limfom (vrsta krvnega raka) ali drugo obliko raka.
In an open-label, singledose, two-treatment, crossover study in healthy volunteers, etanercept administered as a single 50 mg/ml injection was found to be bioequivalent to two simultaneous injections of 25 mg/ml. 
V odprti, enoodmerni, navzkrižni študiji pri zdravih prostovoljcih z dvema oblikama zdravljenja so ugotovili, da je enkratna injekcija 50 mg/ml etanercepta bioekvivalentna dvema sočasnima injekcijama 25 mg/ml.
In part 1, all patients received 0.4 mg/kg (maximum 25 mg per dose) Enbrel subcutaneously twice weekly. 
V prvem delu študije so vsi bolniki 2-krat tedensko prejemali po 0,4 mg/kg (največ 25 mg na odmerek) zdravila Enbrel subkutano.
12 Months 
12 mesecev
The efficacy of Enbrel was compared to methotrexate in a randomised, active-controlled study with blinded radiographic evaluations as a primary endpoint in 632 adult patients with active rheumatoid arthritis (<3 years duration) who had never received treatment with methotrexate. 
V randomizirani študiji, nadzorovani z učinkovino, so s slepo radiografsko oceno kot primarnim opazovanim dogodkom primerjali učinkovitost zdravila Enbrel z učinkovitostjo metotreksata pri 632 odraslih bolnikih z aktivnim revmatoidnim artritisom (trajanje bolezni manj kot 3 leta), ki se pred tem nikoli niso zdravili z metotreksatom.
The possibility exists for TNF-antagonists, including Enbrel, to affect host defences against infections and malignancies since TNF mediates inflammation and modulates cellular immune responses. 
Za antagoniste TNF, vključno z zdravilom Enbrel, velja, da lahko vplivajo na naravno odpornost bolnika proti okužbam in malignim obolenjem, saj TNF sodeluje pri vnetju in uravnava celični imunski odziv.
At 24 weeks, 56% of patients in the Enbrel-treated group had achieved the PASI 75 compared to 5% of placebotreated patients. 
V 24. tednu je 56 % bolnikov doseglo PASI 75 v skupini, zdravljeni z zdravilom Enbrel, v skupini s placebom pa 5 % bolnikov.
Enbrel is supplied as a solution for injection in a pre-filled pen (MYCLIC) (solution for injection). 
Zdravilo Enbrel je na voljo kot raztopina za injiciranje v napolnjenem injekcijskem peresniku (MYCLIC) (raztopina za injiciranje).
Additionally, some patients developed recall injection site reactions characterised by a skin reaction at the most recent site of injection along with the simultaneous appearance of injection site reactions at previous injection sites. 
Poleg tega so nekateri bolniki dobili tako imenovano spominsko lokalno reakcijo na mestu injiciranja; ob naslednjem injiciranju se je poleg reakcije na tedanjem mestu injiciranja sočasno pojavila reakcija tudi na prejšnjih mestih injiciranja.
Powder for solution for injection (powder for injection). 
prašek za raztopino za injiciranje (prašek za injekcijo)
Take the Enbrel carton containing the pre-filled syringes out of the refrigerator and place it on the flat work surface. 
Škatlo z napolnjenimi injekcijskimi brizgami zdravila Enbrel vzemite iz hladilnika in jo odložite na ravno delovno površino.
Mean (SE) Annualized Change from Baseline in Total Sharp Score 
Povprečna (SE) sprememba skupne Sharpove ocene od izhodišča na leto Placebo
Enbrel may be stored at temperatures up to a maximum of 25° C for a single period of up to four weeks; after which, it should not be refrigerated again. 
Zdravilo Enbrel se lahko shranjuje pri temperaturi do največ 25 °C za enkratno obdobje do štirih tednov, po katerem se ga ne sme več ohladiti.
For polyarthritis or extended oligoarthritis in patients from the age of 2 years, or enthesitis-related arthritis or psoriatic arthritis in patients from the age of 12 years, the usual dose is 0.4 mg of Enbrel per kg bodyweight (up to a maximum of 25 mg) given twice weekly, or 0.8 mg of Enbrel per kg of bodyweight (up to a maximum of 50 mg) given once weekly. 
Običajni odmerek zdravila Enbrel za zdravljenje poliartritisa ali razširjenega oligoartritisa pri bolnikih, starejših od 2 let, in za zdravljenje artritisa, povezanega z entezitisom, ali psoriatičnega artritisa pri bolnikih, starejših od 12 let, je 0,4 mg na kg telesne mase (do največ 25 mg) dvakrat na teden ali 0,8 mg na kg telesne mase (do največ 50 mg) enkrat na teden.
Some vaccines, such as oral polio vaccine, should not be given while using Enbrel. 
Med zdravljenjem z zdravilom Enbrel nekaterih cepiv, npr. peroralnega cepiva proti otroški paralizi, ni dovoljeno uporabljati.
Slowly pull the plunger back to draw the liquid into the syringe (see Diagram 7). 
Počasi potegnite bat nazaj, da izvlečete raztopino v brizgo (glejte sliko 7).
Your doctor may decide if you or the child need less anti-diabetic medicine while taking Enbrel. 
Zdravnik lahko odloči, da boste vi ali otrok med jemanjem zdravila Enbrel potrebovali manj zdravila za zdravljenje sladkorne bolezni.
In a controlled clinical trial of two years duration in adult rheumatoid arthritis patients, the combination of Enbrel and methotrexate did not result in unexpected safety findings, and the safety profile of Enbrel when given in combination with methotrexate was similar to the profiles reported in studies of Enbrel and methotrexate alone. 
V dveletnem nadzorovanem kliničnem preskušanju pri odraslih bolnikih z revmatoidnim artritisom ni bilo pri kombiniranem zdravljenju z zdravilom Enbrel in metotreksatom nobenih nepričakovanih ugotovitev glede varnosti; varnostni profil zdravila Enbrel pri kombiniranem zdravljenju z metotreksatom je bil podoben varnostnemu profilu, ki je bil ugotovljen pri monoterapiji z zdravilom Enbrel oziroma metotreksatom.
Your doctor may decide to continue to monitor the child for the presence of infections after the child stops using Enbrel. 
Vaš zdravnik se bo morda odločil, da bo otroka tudi po koncu zdravljenja z zdravilom Enbrel spremljal glede prisotnosti okužb.
In a controlled clinical trial of two years duration in rheumatoid arthritis patients, the combination of Enbrel and methotrexate did not result in unexpected safety findings, and the safety profile of Enbrel when given in combination with methotrexate was similar to the profiles reported in studies of Enbrel and methotrexate alone. 
V dveletnem nadzorovanem kliničnem preskušanju pri bolnikih z revmatoidnim artritisom ni bilo pri kombiniranem zdravljenju z zdravilom Enbrel in metotreksatom nobenih nepričakovanih ugotovitev glede varnosti; varnostni profil zdravila Enbrel pri kombiniranem zdravljenju z metotreksatom je bil podoben varnostnemu profilu, ki je bil ugotovljen pri monoterapiji z zdravilom Enbrel oziroma metotreksatom.
Assemble the additional supplies you will need for your injection. 
Zberite predmete, ki jih boste potrebovali za injekcijo, in jih položite na izbrano površino:
In another open-label single-arm study, 60 patients with extended oligoarthritis (15 patients aged 2 to 4, 23 patients aged 5 to 11 and 22 patients aged 12 to 17 years old), 38 patients with enthesitis-related arthritis (12 to 17 years old), and 29 patients with psoriatic arthritis (12 to 17 years old) were treated with Enbrel at a dose of 0.8 mg/kg (up to a maximum of 50 mg per dose) administered weekly for 12 weeks. 
V drugi odprti študiji z eno skupino se je z zdravilom Enbrel v odmerku 0,8 mg/kg (do največ 50 mg na odmerek) enkrat na teden zdravilo 60 bolnikov z razširjenim oligoartritisom (15 bolnikov, starih od 2 do 4 leta, 23 bolnikov, starih od 5 do 11 let, in 22 bolnikov, starih od 12 do 17 let), 38 bolnikov z artritisom, povezanim z entezitisom (starih od 12 do 17 let) in 29 bolnikov s psoriatičnim artritisom (starih od 12 do 17 let).
Before injection, Enbrel single-use pre-filled syringe should be allowed to reach room temperature (approximately 15 to 30 minutes). 
Pred injiciranjem je treba napolnjene injekcijske peresnike zdravila Enbrel za enkratno uporabo segreti na sobno temperaturo (počakati približno 15 do 30 minut).
ACR 50 Month 3 
ACR 50 3. mesec b
Methotrexate (n = 228) 
Opazovani dogodek metotreksat (n = 228)
The Enbrel solution should not be mixed with any other medicine before use. 
Raztopine zdravila Enbrel pred uporabo ne smete mešati z drugimi zdravili.
Enbrel should not normally be used in children with polyarthritis or extended oligoarthritis below the age of 2 years, or in children with enthesitis-related arthritis or psoriatic arthritis below the age of 12 years, or in children with psoriasis below the age of 6 years. 
Pri otrocih s poliartritisom ali z razširjenim oligoartritisom, mlajših od 2 let, otrocih z artritisom, povezanim z entezitisom, ali s psoriatičnim artritisom, mlajših od 12 let, in otrocih s psoriazo, mlajših od 6 let, se zdravila Enbrel običajno ne sme uporabljati.
T hrombocyt openia, anaemia, leukopenia, neutropenia 
Bolezni krvi in limfatičnega sistema trombocitopenija, anemija, levkopenija, nevtropenija pancitopenija*
Each pack contains 4 single-dose vials and 8 alcohol swabs. 
Eno pakiranje vsebuje 4 enoodmerne viale in 8 alkoholnih blazinic.
Doses of 25 mg of Enbrel (based on dose-finding studies in patients with rheumatoid arthritis) or placebo were administered SC twice a week for 6 months. 
Odmerke zdravila Enbrel po 25 mg (na podlagi študij za ugotovitev odmerkov pri bolnikih z revmatoidnim artritisom) ali placebo so dajali subkutano dvakrat na teden 6 mesecev.
Additionally, the pharmacokinetics of Enbrel in rheumatoid arthritis patients, ankylosing spondylitis and plaque psoriasis patients are similar. 
Farmakokinetika zdravila Enbrel pri bolnikih z revmatoidnim artritisom, ankilozirajočim spondilitisom in psoriazo v plakih je podobna.
The efficacy of Enbrel in ankylosing spondylitis was assessed in 3 randomised, double-blind studies comparing twice weekly administration of 25 mg Enbrel with placebo. 
Učinkovitost zdravila Enbrel pri bolnikih z ankilozirajočim spondilitisom je bila ocenjena v 3 randomiziranih dvojno slepih študijah, kjer so primerjali uporabo 25 mg zdravila Enbrel dvakrat tedensko s placebom.
Patients in this study received a dose of 25 mg or 50 mg Enbrel, or placebo twice a week for 12 weeks and then all patients received open-label 25 mg Enbrel twice weekly for an additional 24 weeks. 
Bolniki v tej študiji so dobivali odmerek 25 mg ali 50 mg zdravila Enbrel ali placebo dvakrat na teden 12 tednov, potem pa so vsi bolniki v odprtem delu dobivali 25 mg zdravila Enbrel dvakrat na teden dodatnih 24 tednov.
Other presentations of Enbrel are available in strengths of 10 mg, 25 mg, and 50 mg. 
Druge oblike zdravila Enbrel so na voljo v jakostih 10 mg, 25 mg in 50 mg.
70b a: 25 mg Enbrel SC twice weekly b: p < 0.001, Enbrel vs. placebo c: p < 0.01, Enbrel vs. placebo 
6. mesec a: 25 mg zdravila Enbrel subkutano dvakrat na teden b: p < 0,001, zdravilo Enbrel v primerjavi s placebom c: p < 0,01, zdravilo Enbrel v primerjavi s placebom
Similarly, the significant advantages for Enbrel monotherapy compared with methotrexate monotherapy were also observed after 24 months. 
Podobno so po 24 mesecih ugotovili tudi pomembne prednosti monoterapije z zdravilom Enbrel pred monoterapijo z metotreksatom.
Re-introduction of treatment with Enbrel after discontinuation of up to 24 months resulted in the same magnitudes of responses as patients who received Enbrel without interruption of therapy based on results of open-label studies. 
Po podatkih iz odprtih študij so bile velikosti odziva po ponovni uvedbi zdravljenja z zdravilom Enbrel po prekinitvah, ki so trajale do 24 mesecev, enake kot pri bolnikih, ki so prejemali zdravilo Enbrel brez prekinitve zdravljenja.
T uberculosis, opportunistic infection (including invasive fungal, protozoal, bacterial, atypical mycobacterial, viral infections, and Legionella)* 
tuberkuloza, oportunistična okužba (vključno z invazivnimi glivičnimi, protozojskimi, bakterijskimi, atipičnimi mikobakterijskimi, virusnimi okužbami in okužbami z bakterijo Legionella)*
There is generally no applicable use of Enbrel in children aged below 2 years in the indication juvenile idiopathic arthritis. 
Zdravila Enbrel se običajno ne uporablja za zdravljenje juvenilnega idiopatskega artritisa pri otrocih, mlajših od 2 let.
Withdrawing the Enbrel solution from the vial 
Jemanje raztopine zdravila Enbrel iz viale
Clinical responses among nr-AxSpa patients who received Enbrel were apparent at the time of the first visit (2 weeks) and were maintained through 2 years of therapy. 
Klinični odzivi pri bolnikih z nr-AxSpa, ki so prejemali Enbrel, so bili vidni ob prvem obisku (po 2 tednih) in so se vzdrževali med celotnim 2-letnim zdravljenjem.
After taking a syringe from the refrigerator, wait approximately 15-30 minutes to allow the Enbrel solution in the syringe to reach room temperature. 
Ko brizgo vzamete iz hladilnika, počakajte približno 15 do 30 minut, da se raztopina zdravila Enbrel v brizgi segreje na sobno temperaturo.
Gather the items that you will need for your injection, and place them on the chosen surface: a. One MYCLIC pre-filled pen and one alcohol swab (take these from the carton of pens you keep in your refrigerator). 
prozorno okence za pregledovanje beli pokrovček igle datum izteka roka uporabnosti zeleni aktivacijski gumb a. En napolnjen peresnik MYCLIC in eno alkoholno blazinico (vzemite ju iz škatle s peresniki, ki jo hranite v hladilniku).
The active ingredient in Enbrel is etanercept. 
Učinkovina zdravila Enbrel je etanercept.
Among patients receiving Enbrel, the clinical responses generally appeared within 1 to 2 weeks after initiation of therapy and nearly always occurred by 3 months. 
Pri bolnikih na zdravilu Enbrel se je klinični odziv običajno pojavil že v prvem ali drugem tednu zdravljenja, skoraj vedno pa je nastopil do 3. meseca.
EU/1/99/126/003 4 vials EU/1/99/126/004 8 vials EU/1/99/126/005 24 vials 
EU/1/99/126/003 4 viale EU/1/99/126/004 8 vial EU/1/99/126/005 24 vial
Etanercept crosses the placenta and has been detected in the serum of infants born to female patients treated with Enbrel during pregnancy. 
Zaznali so ga v serumu dojenčkov, rojenim bolnicam, ki so se med nosečnostjo zdravile z zdravilom Enbrel.
The efficacy of Enbrel in patients with non-radiographic axial spondyloarthritis (nr-AxSpa) was assessed in a randomised, 12-week double-blind, placebo-controlled study. 
Odrasli bolniki z radiografsko nezaznavnim aksialnim spondilartritisom Učinkovitost zdravila Enbrel so pri bolnikih z radiografsko nezaznavnim aksialnim spondilartritisom (nr-AxSpa) ocenili v randomizirani 12-tedenski, dvojno slepi, s placebom nadzorovani študiji.
Serious infections, sepsis, tuberculosis, and opportunistic infections, including invasive fungal infections, listeriosis and legionellosis, have been reported with the use of Enbrel (see section 4.8). 
Pri uporabi zdravila Enbrel so poročali o primerih resnih okužb, sepse, tuberkuloze in oportunističnih okužb, vključno z invazivnimi glivičnimi okužbami, listeriozo in legionelozo (glejte poglavje 4.8).
Choosing an injection site 
Izbira mesta injiciranja
Your doctor may decide to continue to monitor you or the child for the presence of infections after you or the child stop using Enbrel. 
Vaš zdravnik se bo morda odločil, da bo vas ali vašega otroka tudi po koncu zdravljenja z zdravilom Enbrel spremljal glede prisotnosti okužb.
The efficacy of Enbrel was assessed in a randomised, double-blind, placebo-controlled study in 211 paediatric patients aged 4 to 17 years with moderate to severe plaque psoriasis (as defined by a sPGA 
Učinkovitost zdravila Enbrel so ugotavljali v randomizirani, dvojno slepi, s placebom nadzorovani študiji pri 211 pediatričnih bolnikih, starih 4 do 17 let, z zmerno do hudo psoriazo v plakih (definirano z oceno sPGA ≥ 3, ki zajema ≥ 10 % telesne površine (BSA - Body Surface Area), in PASI ≥ 12).
Patients should be tested for HBV infection before initiating treatment with Enbrel. 
Pred uvedbo zdravljenja z zdravilom Enbrel je treba bolnike testirati na okužbo s HBV.